VFF

Business Context and Reporting Period

Company: Village Farms International, Inc. (VFF)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2024
Business Overview: VFF operates four segments: Produce (VF Fresh), Canadian Cannabis (Pure Sunfarms and Rose LifeScience), U.S. Cannabis (Balanced Health), and Energy (VF Clean Energy). The company produces greenhouse-grown vegetables and cannabis products in Canada, the U.S., and internationally.

Key Financial Metrics

Note: Debt figures include Line of Credit ($4,000), Current Maturities ($8,683), and Long-term Debt ($35,736).

Material Changes vs. Prior Period

• Revenue Growth: Sales increased 19% in Q2 2024 and 20% in the first six months of 2024 compared to the prior year. This was driven primarily by a 45% increase in Canadian Cannabis sales and a 7% increase in Produce sales.
• Impairment Charges: The company recorded a non-cash impairment charge of $11,939 in Q2 2024 related to goodwill and intangible assets in the U.S. Cannabis segment. This charge was the primary driver of the net loss for the quarter.
• Profitability: Gross margins declined across the Produce and U.S. Cannabis segments due to weaker market pricing and product mix shifts. The Canadian Cannabis segment maintained stable gross profit dollars but saw a margin percentage decline due to a shift toward lower-margin non-branded sales.
• Acquisition: In May 2024, VFF acquired an additional 10% interest in Rose LifeScience for approximately $3,016, increasing its ownership to 80%.
• Legal Settlement Impact: The prior year period (Q2 2023) included a one-time legal settlement gain of $5,584 related to the ToBRFV virus infestation, which is not present in the current period.

Guidance, Outlook, and Risks

• U.S. Cannabis Outlook: Management cites challenges from the proliferation of unregulated hemp-derived products and new state restrictions on CBD sales, leading to the full impairment of the U.S. Cannabis segment's goodwill and brand intangibles.
• Canadian Cannabis: The segment continues to gain market share, holding the number two national position. International exports to Germany, the UK, and Israel are ongoing. The company is building a facility in the Netherlands with production targeted for Q4 2024.
• Produce Segment: The company is implementing AI and new cultivation technologies to improve yields and reduce costs. A sale process is ongoing for the Monahans, Texas greenhouse facility.
• Liquidity: Management believes existing cash, operating cash flow, and credit facilities (including a recently extended Operating Loan maturing in 2027) are sufficient for the next 12 months. The company was in compliance with all covenants as of June 30, 2024.
• Internal Controls: The company disclosed a material weakness in internal controls over financial reporting related to the calculation of fair value for goodwill and intangible assets. A remediation plan is underway with expected completion by December 31, 2024.

Key Facts for Investor Verification

• Impairment Validity: Verify the assumptions used in the discounted cash flow analysis for the $11.9M U.S. Cannabis impairment, specifically regarding future cash flows and discount rates.
• Debt Covenants: Monitor compliance with financial covenants, particularly the FCC Term Loan, which requires annual testing (next date: Dec 31, 2024).
• Produce Margins: Track the impact of weaker market pricing on the VF Fresh segment's ability to return to positive gross margins.
• Internal Control Remediation: Confirm the successful implementation of the remediation plan for the material weakness in financial reporting controls by year-end 2024.
• Regulatory Environment: Monitor evolving regulations regarding CBD and hemp-derived products in the U.S., which directly impact the U.S. Cannabis segment's revenue potential.